Pdf Current Treatment Approaches For Thymic Epithelial Tumors Thymic epithelial tumors (tets), including thymoma, thymic carcinoma and neuroendocrine tumors, are uncommon tumors that originate from the epithelial cells of the thymus. nevertheless, despite their rarity, they represent the most common tumor type located in the anterior mediastinum. For patients with advanced or metastatic tets, platinum based chemotherapy remains the standard first line treatment; however, some new drugs and combinations are currently under evaluation.
Pdf Imaging Of Thymic Epithelial Tumors A Clinical Practice Review Thymic epithelial tumors (tets), including thymoma, thymic carcinoma and neuroendocrine tumors, are uncommon tumors that originate from the epithelial cells of the thymus. nevertheless, despite their rarity, they represent the most common tumor type located in the anterior mediastinum. By synthesizing recent progress and highlighting key areas for future investigation, this review aims to support the development of evidence based, personalized treatment approaches and ultimately improve clinical outcomes for patients with tets. The goal of this guideline is to provide clini cians with guidance on how to treat patients with thymic epithelial tumors, including thymoma, thymic carcinoma, and thymic neuroendocrine tumors (nets). Numerous agents, either alone or in combination regimens, have been tested for activity in both thymomas and thymic carcinoma. this review details current chemothera peutic options and potential future developments in the medical treatment of this intriguing malignancy.
Pdf The Molecular Landscape Of Thymic Epithelial Tumors A The goal of this guideline is to provide clini cians with guidance on how to treat patients with thymic epithelial tumors, including thymoma, thymic carcinoma, and thymic neuroendocrine tumors (nets). Numerous agents, either alone or in combination regimens, have been tested for activity in both thymomas and thymic carcinoma. this review details current chemothera peutic options and potential future developments in the medical treatment of this intriguing malignancy. In conclusion, median sternotomy is the standard approach for the treatment of thymic tumors, but the role of minimally invasive surgery in stage i and ii tumors is stead ily growing. By synthesizing recent progress and highlighting key areas for future investigation, this review aims to support the development of evidence based, personalized treatment approaches and ultimately improve clinical outcomes for patients with tets. The nccn guidelines for thymomas and thymic carcinomas provide guidance for the diagnosis, treatment, and surveillance of patients with thymoma and thymic carcinoma. Selected relevant indications related to the diagnostic and staging work up, as well as to surgical, radiotherapic, and systemic treatment management of patients with tet, are reported in the main text of this paper.
Comments are closed.